The State of Wisconsin’s Medical Examining Board (MEB) modified its plan for requiring most physicians to take controlled substances prescribing-specific continuing medical education (CME) as part of the 30-credit biennial requirement. The group held its monthly meeting Wednesday in Madison.
The proposal to modify chapter MED 13 of the administrative code begins on page 14 of this month’s agenda. The MEB is expected to finalize the rule proposal at its September meeting, but the final rule will likely differ from the proposal as laid out in the agenda in two major ways:
- Rather than tie the requirement to take specific CME to the CME biennial cycle—which varies based on whether a physician has an MD or a DO—the MEB will require physicians with a Drug Enforcement Administration (DEA) license to take two credits of MEB-approved CME in the 2017 calendar year and then again in the 2019 calendar year.
- The MEB modified the focus of the coursework to make it clear that any approved class will concentrate on the newly approved opioid prescribing guidelines (available here) rather than being an element in broader prescribing coursework.
MEB staff still need to tackle the real-world ramifications of the proposed changes to the rule; they will report back to the MEB in September.
For more information, e-mail Mark Grapentine, JD, in the Society’s Government and Legal Affairs Department.
Back to August 18, 2016 Medigram